Anbio Biotechnology (NASDAQ:NNNN) Shares Up 5.3% – Time to Buy?

Anbio Biotechnology (NASDAQ:NNNN) shot up 5.3% during trading on Friday . The company traded as high as $25.99 and last traded at $26.3950. 2,602 shares changed hands during trading, a decline of 94% from the average session volume of 45,977 shares. The stock had previously closed at $25.07.

Analysts Set New Price Targets

Separately, Weiss Ratings lowered Anbio Biotechnology from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Wednesday, April 1st. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, Anbio Biotechnology has an average rating of “Sell”.

Anbio Biotechnology Price Performance

The stock’s 50-day simple moving average is $25.26.

Anbio Biotechnology (NASDAQ:NNNN) last announced its quarterly earnings data on Tuesday, April 7th. The company reported $0.03 EPS for the quarter.

About Anbio Biotechnology

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.